We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Rapid, Cost Effective Method for Identifying UTI-Causing Bacteria

By LabMedica International staff writers
Posted on 01 Feb 2012
A new method for identifying bacteria that cause urinary tract infections (UTIs) will lead to faster, more effective treatment as well as a reduction in costs.

Scientists in Germany tested urine samples from hospitalized patients and were able to effectively separate and accurately identify bacteria using Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) mass spectrometry.

The MALDI-TOF technique identifies bacteria by analyzing their proteins directly from the urine sample. More...
MALDI-TOF mass spectrometry works by firing pulses of UV light at biological samples. All the particles become charged and are then forced down a tunnel by an electrical force.

The speed of the particles depends on their mass; thus, biomolecules such as proteins or DNA can be identified. As bacteria do not need to be cultured on agar, the MALDI-TOF method reduces the time to identify UTI-causing bacteria to less than 30 minutes. In addition, MALDI-TOF can detect and identify bacteria at much lower levels than are needed for current standard diagnostic techniques.

The study was performed by scientists at the University Hospital Essen in Germany. Dr. Frank Mosel, who led the study, believes the MALDI-TOF method will have huge benefits for patients who suffer from UTIs. Dr. Mosel said, "Identifying bacteria quickly and accurately using MALDI-TOF means treatment for UTIs can be started at an early stage and with an antibiotic targeted at the correct bacterial culprit."

The MALDI-TOF technique is unaffected by any antibiotics the patient may have taken and the bacteria sample does not need to be cultured before testing. The sensitivity of the test is nearly 100 times higher than the minimum clinical threshold for UTI diagnosis.

Dr. Mosel believes that the use of MALDI-TOF mass spectrometry could be extended more widely as a medical analysis tool. "This method could quite feasibly be extended to blood, cerebrospinal fluid, and other bodily fluids to detect bacteria or even fungi," he said.

However, there are certain limitations to the MALDI-TOF methods for identifying bacteria. For example, bacteria in urine samples from patients who had undergone surgery for lower urinary tract (e.g., bladder) cancers could not be detected because human proteins produced interfered with the urine analysis.

Related Links:

University Hospital Essen



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LiDia-SEQ aims to deliver near-patient NGS testing capabilities to hospitals, labs and clinics (Photo courtesy of DNAe)

World's First NGS-Based Diagnostic Platform Fully Automates Sample-To-Result Process Within Single Device

Rapid point-of-need diagnostics are of critical need, especially in the areas of infectious disease and cancer testing and monitoring. Now, a direct-from-specimen platform that performs genomic analysis... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.